The Human Papillomavirus ( Hpv )

Human Papilloma Virus, more commonly known as HPV, is a sexually transmitted virus. It is spread from skin-to-skin contact with an infected person, typically during sexual encounters. It is the most common sexually transmitted disease in the United States. According to the Immunize Action Coalition, “most sexually active American men and woman will contract at least one type of HPV virus during their lifetime” (A Parent 's Guide to Preteen, 2013, p. 1). To put the numbers in perspective, it infects an estimated seventy-nine million Americans today with approximately fourteen million more people being affected additionally each year (Human

According to the Centers for Disease Control and Prevention (CDC), Human papillomavirus (HPV) infects roughly 20 million individuals in the United States with 6.1 million new cases each year. There is no cure for HPV, only treatment for associated health problems. There are more than 30 strains of HPV that affect more than half of sexually active individuals in their lifetime. Public health risks involve several types of HPV leading to precancerous lesions and causing 70% of cervical cancer. Cervical cancer, the second most common cancer, affects many women globally. In the United States, nearly 10,000 women are diagnosed with cervical cancer annually and 3,700 of those women die. It has been reported by American Cancer Society that with early

Human papillomavirus (HPV) is the most common sexually transmitted disease (STD) and can affect many sexually active individuals throughout their lifetimes and is spread through anal, oral and vaginal sex (CDC, 2016). HPV currently affects 79 million Americans with 14 million new cases of infection every year and is so pervasive most sexually-active individuals will encounter some form of the virus during their lives (CDC, 2016). HPV can be troublesome to detect as symptoms can develop years after initial infection or may not be seen at all, but in many cases HPV does not cause lasting health problems (CDC, 2016).

Human Papilloma Virus (HPV) is a double stranded DNA virus. There are many genotypes HPV and some of them are oncogenic. They have envelope proteins E6 and E7 on their cell wall which are associated to initiate cancer. Anogenital lesions associated to HPV are divided into ‘low-risk’ types (6, 11, 34, 40, 42, and 43) and ‘high risk’ types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 69, 73, and 82). Most of the low risk HPV infections are asymptomatic and are not fatal, however infection to high risk HPV such as type 16 and 18 may cause cervical, anal, vaginal, vulvar and penile cancer (Centre of Disease Control, 2012). Low risk HPV generally cause warts on the skin surface which rarely develop into malignancy. Type 16 and 18 both were originally isolated from cervical carcinomas of human body. More than 70% of human cervical is due to the infection of either HPV 16 or 18. According to CDC, in 2008 it was estimated 11,070 cases of cervical cancer in United States and about 3,870 deaths due to cervical cancer. Higher percentage of HPV persistent infection occurs by HPV-16 and the risk of getting cervical cancer due the progression of disease is higher for HPV 16 and 18 and 45 (Tino F. Schwarz, 2008).

Most sexually active individuals will have detectable human papillomavirus (HPV) at least once in their lifetime. 14 million people are infected annually, and 79 million people have the prevalent infection. Approximate 5% of the cancers globally are HPV-associated anogenital or oral cancers (1). HPV is transmitted frequently between partners; more frequent transmission has been reported from females to males than from males to females (2). The incidence of anal and oral cancers related to HPV is increasing in the general population and is growing even faster among individuals who are immunocompromised because of human immunodeficiency virus (HIV) infection (3, 4). Two prophylactic vaccines (Gardasil and Cervarix) have been approved for a decade. Recently, the nonavalent vaccine including additional high-risk HPV types is promised to provide more coverage against cervical cancers (5). The HPV vaccine is recommended

Human papillomavirus (HPV) is the most prevalent virus in the human population. Almost all people will be exposed to HPV infections in their lifetime. HPV-associated cancers comprise 5% of all human cancers. Two prophylactic vaccines that are designed to block the four most prevalent HPV types (>150 types) in the genital infection have reduced the incidence in the vaccinated population. However, the vaccines offer no therapeutic effect against pre-existing infections. Furthermore, the vaccination completion rate was 26 % overall. The large unvaccinated population will continue to be at the risk of developing HPV-associated diseases and cancers until an effective treatment is available.

The human papilloma virus (HPV) is the most common sexually transmitted disease, with a worldwide point prevalence of 11.7%., in the United States over 79 million people are already infected with HPV, and over 14 million new HPV infections occur each year CITE 1,2,5. HPV affecting both men and women, has an estimated lifetime prevalence of 80-90%, it is likely that most sexually active people will become infected with HPV before the age of 45 CITE 1, 3. Although over 100 HPV genotypes have been identified, only 40 infect the genital area. These 40 are further subdivided into high risk oncogenic genotypes, and low risk the genotypes responsible for genital warts and recurrent papillomatosis CITE 8,3. HPV is associated with virtually all cervical cancers, and over 90% of anal cancers CITE 1. The cost of preventing and treating HPV and its associated diseases is estimated at eight billion dollars annually

According to the National Cancer Institute, there were an estimated 12,360 new cases of cervical cancer and 4020 deaths in 2014. Seventy percent of these cases were caused by the human papillomavirus (HPV). HPV is a virus “spread by skin-to-skin contact” (Alexander, et al. 199). This virus can cause warts on the hands, feet, genital areas, of which 90% are caused from HPV, but in addition to cervical cancer, it may also cause cancer in many other parts of the body including head, neck, anal, and penial (Krishnan 2). All of this sounds pretty scary, however, much of it could be avoided with a simple series of HPV vaccinations. All of

Do you know that over ninety percent of people who are sexually active will have come in contact with HPV at least once in his/her lifetime? Human Papilloma Virus, also known as HPV, is an infectious emerging disease that has become one of the number one causes of cervical cancer in women. With a startling increase in HPV prevalence research has been encouraged to discover more about this virus and how it causes cervical cancer. Fifteen years ago, not many knew what HPV was and there was very little research conducted on the virus. Since such little information was known about it, HPV was not even taught in the Sexual Education class as a sexually transmitted virus. Throughout years of research scientists, doctors, and medical staff

Human papillomavirus, otherwise known as HPV, is the most prevalent sexually transmitted infection in North America (Dell et al. 2000; Gross 2014). Awareness of human papillomavirus is rather low and is often overshadowed by infections with much more noticeable symptoms such as gonorrhea and syphilis. The disease is usually associated with women due to its association with cervical cancer (Dell et al. 2000), and men are often overlooked. However, males are at risk just as much as females. There is plenty of evidence showing that human papillomavirus has detrimental effects to male health, yet females are usually the ones tested for the disease and are vaccinated. With today’s advancements in medicine, vaccinations should be administered to everyone to vastly reduce the prevalence of human papillomavirus, yet it is the most common STI. If males were vaccinated as much as females, highly preventable effects of human papillomavirus would diminish amongst the world population. Worldwide governments and public health agencies should fund HPV vaccination for males as well as females.

There has been many cases reported a year of people infected with various sexually transmitted infections. There are number of STI’s that are known to be common due to how often it’s contracted, tested, reported and treated. Currently, one of the main STIs that have become more common and is a major public health concern in the United States is the Human papilloma virus, also better known as HPV. Human Papilloma virus (HPV) has created a rapid spread among many individuals who have become exposed due to sexual contact with those who are infected. HPV is linked to many cancers, commonly cervical cancer among woman. HPV

Sexually transmitted infections (STIs) has been a persisting public health problem throughout the world. While some STIs, like gonorrhea, are curable, other STIs like human papillomavirus (HPV), have no cure and can lead to deadly consequences. Unfortunately, HPV is considered to be the most common type of sexually transmitted infection. Like all STIs, HPV spread through sexual contact with an infected person, whether it be vaginal, anal, or oral sex. According to the Centers for Disease Control and Prevention, there are about 79 million Americans infected with HPV at a time and about 14 million new cases arise every year (“Human Papillomavirus (HPV)”). This means that about one in four people are infected with some type

Human papillomavirus, commonly abbreviated as HPV, is the most common sexually transmitted virus that can cause a variety of diseases. It is transferred from person to person by either genital contact or from oral contact. Most men and women who are sexually active will be infected with this virus at least once in their life (“HPV”). A reason why HPV has become such a big problem in society is because of the fact that it is a virus, and thus cannot be treated with antibiotics. For other viral infections, it is possible to wait for the body’s immune system to rid the body of the foreign invader, but HPV is a virus that can cause more serious health problems such as genital warts, cancers of the mouth, anus, or vagina, as well as the cervix. Another reason why this problem exists in society may be due to more relaxed standards regarding sexual activity. In today’s society, people are more likely to have more than one sexual partner, making it easier for the virus to spread within the population. People are also becoming sexually active at younger ages before they receive education about safe sex at school or at home, which is also a factor in the spread of HPV in the population. Most people do not exhibit negative symptoms from the virus; indeed, some of them may not even know they have contracted it, for the body can clear out the virus on its own ninety percent of the time (“What is HPV?” 2013). HPV

Cervical cancer affects about 200 women in New Zealand per year and almost 70 women die every year because of it. This commonly happens to women whom are in their 30’s and often with no symptoms (Southern Cross, 2015). This problem is caused by a type of human papilloma virus or HPV which is commonly transmitted thru sexual contact and an estimated count of 80% on sexually active women are affected in their lives. About 40 types of Human Papilloma Virus are linked with

Background: Human Papillomavirus (HPV) is the most common sexually transmitted infection and will occur in the life of a sexually active man or woman. It is associated with causing cancers of the anus, penis, vulva, vagina and cervix. Currently, there are no screening methods for males, only females (CDC2014). This review examines the role of men in the transmission of HPV and why there are no screening recommendations in males.